IMS Lectures in 2021
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Trump to Shut Off Tiktok, Wechat to New U.S. Users on Sunday
For news and information consider- If you would like to share news or news organization events, and school Mr. Lee’s Commen- ation, please send to If information with our readers, please news to us includinig your name and [email protected] tary and Dairy send the unique stories, business phone number in case more informa- tion is needed. or contact John Robbins 832-280-5815 Jun Gai 281-498-4310 Publisher: Wea H. Lee President: Catherine Lee Editor: John Robbins, Jun Gai Address: 11122 Bellaire Blvd., Houston, TX 77072 E-mail: [email protected] Southern Daily News is published by Southern News Group Daily Inside C2 Saturday September 19 2020 | www.today-america.com | Southern News Group Trump to shut off TikTok, WeChat to new U.S. users on Sunday WASHINGTON (Reuters) - The Trump administration WeChat developer Tencent Holdings’ called the order will ban WeChat and video-sharing app TikTok from U.S. “We have some great options and maybe we can keep a lot of “unfortunate” but said it “will continue to discuss with app stores starting Sunday night, a move that will block people happy,” Trump told reporters. “We have to have the total the government and other stakeholders in the U.S. ways Americans from downloading the Chinese-owned plat- security from China.” to achieve a long-term solution.” forms over concerns they pose a national security threat. Commerce Secretary Wilbur Ross told Fox Business Network that The Commerce Department order bars Apple Inc’s app The bans, announced on Friday, affect only new “the basic TikTok will stay intact until Nov. -
Emerging Leaders in Biosecurity Initiative
Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles. -
The Annual MIDAS Network Meeting Takes Place April 3-5, 2018, at the Hyatt Regency Bethesda. Registration and Other Informatio
MIDAS CIDID Newsletter #14 View this email in your browser Issue #14 | February 2018 Welcome to the February 2018 edition of the MIDAS CIDID Newsletter. This is where you can nd Center-wide updates, along with relevant news and highlights. CIDID Website CIDID Twitter The annual MIDAS Network Meeting takes place April 3-5, 2018, at the Hyatt Regency Bethesda. Registration and other information is available on the MIDAS meeting website. The 10th Summer Institute in Statistics and Modeling in Infectious Diseases (SISMID) takes place July 9-25, 2018, at the University of Washington in Seattle. Registration and scholarship information is available on the SISMID website. Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico AJTMH [pdf] An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014–2015 AJTMH [pdf] Core pertussis transmission groups in England and Wales: A tale of two eras Vaccine [pdf] Resilience management during large-scale epidemic outbreaks Scientic Reports [pdf] Panel data analysis via mechanistic models arXiv [pdf] Models and analyses to understand threats to polio eradication BMC Medicine [pdf] Comparative epidemiology of poliovirus transmission Scientic Reports [pdf] Silent circulation of poliovirus in small populations Infectious Disease Modeling [pdf] Steve Bellan, Natalie Dean, and Ira Longini contributed to the development of an interactive web-based decision tool, InterVax, to assist in the design of vaccine efcacy trials during emerging outbreaks. This work is part of the ongoing World Health Organization (WHO) Research and Development Blueprint for Action to Prevent Epidemics. CIDID John Drake is a co-author on a paper that will be read at the Royal Statistical Society on March 14, 2018. -
International Research and Exchanges Board Records
International Research and Exchanges Board Records A Finding Aid to the Collection in the Library of Congress Prepared by Karen Linn Femia, Michael McElderry, and Karen Stuart with the assistance of Jeffery Bryson, Brian McGuire, Jewel McPherson, and Chanté Wilson-Flowers Manuscript Division Library of Congress Washington, D.C. 2011 International Research and Exchanges Board Records Page ii Collection Summary Title: International Research and Exchanges Board Records Span Dates: 1947-1991 (bulk 1956-1983) ID No: MSS80702 Creator: International Research and Exchanges Board Creator: Inter-University Committee on Travel Grants Extent: 331,000 items; 331 cartons; 397.2 linear feet Language: Collection material in English and Russian Repository: Manuscript Division, Library of Congress, Washington, D.C. Abstract: American service organization sponsoring scholarly exchange programs with the Soviet Union and Eastern Europe in the Cold War era. Correspondence, case files, subject files, reports, financial records, printed matter, and other records documenting participants’ personal experiences and research projects as well as the administrative operations, selection process, and collaborative projects of one of America’s principal academic exchange programs. International Research and Exchanges Board Records Page iii Contents Collection Summary .......................................................... ii Administrative Information ......................................................1 Organizational History..........................................................2 -
Framework on Accumulating Evidence Across Outbreaks
Framework on accumulating evidence across outbreaks NATALIE DEAN DEPARTMENT OF BIOSTATISTICS UNIVERSITY OF FLORIDA WHO R&D BLUEPRINT CONSULTATION ON CLINICAL TRIAL DESIGNS NOVEMBER 29, 2018, GENEVA Kennedy et al. (2016) DOI: 10.1177/1740774515621037 2 Figure: Weekly incidence of Ebola in Guinea 2014–15, and key dates in the ring vaccination trial 3 doi:10.1126/science.aav3996 4 National Academies of Sciences, Engineering, and Medicine (2017) https://doi.org/10.17226/24739 5 http://www.who.int/emergencies/mers-cov/epi-18-september-2018.png 6 Motivation Outbreaks are of unpredictable size and duration All outbreaks represent an opportunity to advance research and development efforts There is considerable risk that trials will be underpowered and results from trials terminated due to low accrual will be inconclusive Prejudgment of promising but inconclusive results can: . Impact decision-making of caregivers and policy makers . Jeopardize the conduct of future confirmatory trials 7 Recommended approach We advocate for the use of a “master protocol” to preserve data confidentiality and trial integrity until the scientific aims have been reliably addressed Master protocol = conventional clinical trial designed to extend across multiple sites and outbreaks Trial results are released only following the advice of an independent data monitoring committee (e.g. stop for efficacy, futility, reached target # of endpoints) and not due to lack of recruitment 8 Practical considerations Multi-site trial in high-risk areas with opportunity to add sites -
MIDAS-CIDID-Newsletter-15-June-2018.Pdf
MIDAS CIDID Newsletter #15 View this email in your browser Issue #15 | June 2018 Welcome to the June 2018 edition of the MIDAS CIDID Newsletter. This is where you can nd Center-wide updates, along with relevant news and highlights. CIDID Website CIDID Twitter The 10th Summer Institute in Statistics and Modeling in Infectious Diseases (SISMID) takes place July 9-25, 2018, at the University of Washington in Seattle. Registration information is available on the SISMID website. CIDID Seminar: Pelton Auditorium, Fred Hutch August 7, 2018, 10:00 - 11:00am Speaker: Adam Lauring Inuenza Evolution... Getting Personal Live video stream and recording available: [link] Transmission-clearance trade-offs indicate that dengue virulence evolution depends on epidemiological context Nature Communications [pdf] Transmissibility of Norovirus in Urban versus Rural Households in a Large Community Outbreak in China Epidemiology [pdf] Quantifying the risk of local Zika virus transmission in the continental US during the 2015-2016 ZIKV epidemic bioRxiv [pdf] How single mutations affect viral escape from broad and narrow antibodies to H1 inuenza hemagglutinin Nature Communications [pdf] Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 inuenza variants bioRxiv [pdf] Inuenza A(H7N9) Virus Antibody Responses in Survivors 1 Year after Infection, China, 2017 Emerging Infectious Diseases [pdf] The impact of past vaccination coverage and immunity on pertussis resurgence Science Translational Medicine [pdf] High dimensional random walks can appear low dimensional: Application to inuenza H3N2 evolution Journal of Theoretical Biology [pdf] Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico PLoS Neglected Tropical Diseases [pdf] Design of vaccine trials during outbreaks with and without a delayed vaccination comparator Annals of Applied Statistics [pdf] Modeling and Inference for Infectious Disease Dynamics: A Likelihood- Based Approach Statistical Science [pdf] Nextstrain continues to expand its repertoire of pathogens. -
See Who Attended
Company Name First Name Last Name Job Title Country 24Sea Gert De Sitter Owner Belgium 2EN S.A. George Droukas Data analyst Greece 2EN S.A. Yannis Panourgias Managing Director Greece 3E Geert Palmers CEO Belgium 3E Baris Adiloglu Technical Manager Belgium 3E David Schillebeeckx Wind Analyst Belgium 3E Grégoire Leroy Product Manager Wind Resource Modelling Belgium 3E Rogelio Avendaño Reyes Regional Manager Belgium 3E Luc Dewilde Senior Business Developer Belgium 3E Luis Ferreira Wind Consultant Belgium 3E Grégory Ignace Senior Wind Consultant Belgium 3E Romain Willaime Sales Manager Belgium 3E Santiago Estrada Sales Team Manager Belgium 3E Thomas De Vylder Marketing & Communication Manager Belgium 4C Offshore Ltd. Tom Russell Press Coordinator United Kingdom 4C Offshore Ltd. Lauren Anderson United Kingdom 4Cast GmbH & Co. KG Horst Bidiak Senior Product Manager Germany 4Subsea Berit Scharff VP Offshore Wind Norway 8.2 Consulting AG Bruno Allain Président / CEO Germany 8.2 Consulting AG Antoine Ancelin Commercial employee Germany 8.2 Monitoring GmbH Bernd Hoering Managing Director Germany A Word About Wind Zoe Wicker Client Services Manager United Kingdom A Word About Wind Richard Heap Editor-in-Chief United Kingdom AAGES Antonio Esteban Garmendia Director - Business Development Spain ABB Sofia Sauvageot Global Account Executive France ABB Jesús Illana Account Manager Spain ABB Miguel Angel Sanchis Ferri Senior Product Manager Spain ABB Antoni Carrera Group Account Manager Spain ABB Luis andres Arismendi Gomez Segment Marketing Manager Spain -
Framework for Equitable Allocation of COVID-19 Vaccine (2020)
THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25917 SHARE Framework for Equitable Allocation of COVID-19 Vaccine (2020) DETAILS 260 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-68224-4 | DOI 10.17226/25917 CONTRIBUTORS GET THIS BOOK Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Health FIND RELATED TITLES and Medicine Division; National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Framework for Equitable Allocation of COVID-19 Vaccine Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors Committee on Equitable Allocation of Vaccine for the Novel Coronavirus Board on Health Sciences Policy Board on Population Health and Public Health Practice Health and Medicine Division PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. -
Turtles Without Borders Sea Turtles Are Rebounding, but Much Work Remains Fall 2019, Vol
FALL 2019 Turtles Without Borders Sea Turtles Are Rebounding, But Much Work Remains Fall 2019, Vol. 24, No. 3 Extracts Research briefs 5 Turtles Without Borders Sea turtles are rebounding, but much work remains 14 Center of Excellence UF grows $10 million grant into $1.7 billion gene therapy 24 company Brammer Bio RandallRuiz; cover photo, DavidTroeger Dr. Kent Fuchs President Dr. David Norton Vice President for Research Board of Trustees Mori Hosseini, Chair David L. Brandon James W. Heavener Leonard H. Johnson Thomas G. Kuntz Michael C. Murphy Daniel T. O’Keefe Rahul Patel Marsha D. Powers Jason J. Rosenberg Robert G. Stern Ray G. Thomas Anita G. Zucker Explore is published by UF Research. Opinions expressed do not reflect the official views of the university. Use of trade names implies no endorsement by the University of Florida. © 2019 University of Florida. The Writing Life explore.research.ufl.edu The University of Florida’s Editor: creative writing program Joseph M. Kays nurtures and pushes its [email protected] graduate students 30 Art Director: Katherine Kinsley-Momberger Design and Illustration: Katherine Kinsley-Momberger Ivan J. Ramos Mr. IPO Writers: Jay Ritter has spent his career Joseph Kays Cindy Spence tracking the emergence of new public companies Photography: John Jernigan 38 Charlotte Kesl Web Editor: Jewel Midelis Copy Editor: Bruce Mastron The Conversation Printing: Changing Tech's Face StorterChilds Printing, Gainesville Member of the University Research Magazine Association 42 www.urma.org Building a Better World Being forward-focused on a worthy goal is an essential attribute of any individual or organization that seeks relevance and impact in a complex endeavor. -
Surname First Name Categorisation Abadin Jose Luis Silver Abbelen
2018 DRIVERS' CATEGORISATION LIST Updated on 09/07/2018 Drivers in red : revised categorisation Drivers in blue : new categorisation Surname First name Categorisation Abadin Jose Luis Silver Abbelen Klaus Bronze Abbott Hunter Silver Abbott James Silver Abe Kenji Bronze Abelli Julien Silver Abergel Gabriele Bronze Abkhazava Shota Bronze Abra Richard Silver Abreu Attila Gold Abril Vincent Gold Abt Christian Silver Abt Daniel Gold Accary Thomas Silver Acosta Hinojosa Julio Sebastian Silver Adam Jonathan Platinum Adams Rudi Bronze Adorf Dirk Silver Aeberhard Juerg Silver Afanasiev Sergei Silver Agostini Riccardo Gold Aguas Rui Gold Ahlin-Kottulinsky Mikaela Silver Ahrabian Darius Bronze Ajlani Karim Bronze Akata Emin Bronze Aksenov Stanislas Silver Al Faisal Abdulaziz Silver Al Harthy Ahmad Silver Al Masaood Humaid Bronze Al Qubaisi Khaled Bronze Al-Azhari Karim Bronze Alberico Neil Silver Albers Christijan Platinum Albert Michael Silver Albuquerque Filipe Platinum Alder Brian Silver Aleshin Mikhail Platinum Alesi Giuliano Silver Alessi Diego Silver Alexander Iradj Silver Alfaisal Saud Bronze Alguersuari Jaime Platinum Allegretta Vincent Silver Alleman Cyndie Silver Allemann Daniel Bronze Allen James Silver Allgàuer Egon Bronze Allison Austin Bronze Allmendinger AJ Gold Allos Manhal Bronze Almehairi Saeed Silver Almond Michael Silver Almudhaf Khaled Bronze Alon Robert Silver Alonso Fernando Platinum Altenburg Jeff Bronze Altevogt Peter Bronze Al-Thani Abdulrahman Silver Altoè Giacomo Silver Aluko Kolawole Bronze Alvarez Juan Cruz Silver Alzen -
Michael Z. Vinokouroff: a Profile and Inventory of His Papers And
MICHAEL Z. VINOKOUROFF: A PROFILE AND INVENTORY OF HIS PAPERS (Ms 81) AND PHOTOGRAPHS (PCA 243) in the Alaska Historical Library Louise Martin, Ph.D. Project coordinator and editor Alaska Department of Education Division ofState Libraries P.O. Box G Juneau Alaska 99811 1986 Martin, Louise. Michael Z. Vinokouroff: a profile and inventory of his papers (MS 81) and photographs (PCA 243) in the Alaska Historical Library / Louise Martin, Ph.D., project coordinator and editor. -- Juneau, Alaska (P.O. Box G. Juneau 99811): Alaska Department of Education, Division of State Libraries, 1986. 137, 26 p. : ill.; 28 cm. Includes index and references to photographs, church and Siberian material available on microfiche from the publisher. Partial contents: M.Z. Vinokouroff: profile of a Russian emigre scholar and bibliophile/ Richard A. Pierce -- It must be done / M.Z.., Vinokouroff; trans- lation by Richard A. Pierce. 1. Orthodox Eastern Church, Russian. 2. Siberia (R.S.F.S.R.) 3. Russian Orthodox Greek Catholic Church of America--Diocese of Alaska--Archives-- Catalogs. 4. Vinokour6ff, Michael Z., 1894-1983-- Library--Catalogs. 5. Soviet Union--Emigrationand immigration. 6. Authors, Russian--20th Century. 7. Alaska Historical Library-- Catalogs. I. Alaska. Division of State Libraries. II. Pierce, Richard A. M.Z. Vinokouroff: profile of a Russian emigre scholar and bibliophile. III. Vinokouroff, Michael Z., 1894- 1983. It must be done. IV. Title. DK246 .M37 Table of Contents Introduction ............................................. 1 “M.Z. Vinokouroff: Profile of a Russian Émigré Scholar and Bibliophile,” by Richard A. Pierce................... 5 Appendix: “IT MUST BE DONE!” by M.Z. Vinokouroff; translation by Richard A. -
What the Lightning-Fast Quest for Covid Vaccines Means
Feature MICHAEL CLEVENGER/GETTY The first US shipments of the joint Pfizer–BioNTech COVID-19 vaccine were ready by mid-December. making vaccines, such as by using messenger RNA (mRNA), have been validated by the WHAT THE LIGHTNING-FAST COVID-19 response, he adds. “It has shown that the development process can be accelerated QUEST FOR COVID VACCINES substantially without compromising on safety.” The world was able to develop COVID-19 MEANS FOR OTHER DISEASES vaccines so quickly because of years of pre- vious research on related viruses and faster The speedy approach used to tackle SARS-CoV-2 could ways to manufacture vaccines, enormous funding that allowed firms to run multiple change the future of vaccine science. By Philip Ball trials in parallel, and regulators moving more quickly than normal. Some of those factors might translate to other vaccine efforts, par- ticularly speedier manufacturing platforms. But there’s no guarantee. To repeat such hen scientists began seeking That speed of advance “challenges our rapid success will require similar massive fund- a vaccine for the SARS-CoV-2 whole paradigm of what is possible in vaccine ing for development, which is likely to come coronavirus in early 2020, they development”, says Natalie Dean, a biostatisti- only if there is a comparable sense of social were careful not to promise cian at the University of Florida in Gainesville. and political urgency. It will depend, too, on quick success. The fastest It’s tempting to hope that other vaccines might the nature of the pathogen. With SARS-CoV-2, any vaccine had previously now be made on a comparable timescale.